MedTrace Logo

Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People

NCT03671629 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2024-12-20

No results posted yet for this study

Summary

This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.

Conditions

  • Drug Use

Interventions

OTHER

Enhanced clinical pharmacist service

The intervention includes regular medical chart reviews, multiple patient interviews and, if needed, collaboration with the primary care physician.

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Maria Gustafsson, Ph.D · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-19
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03671629 on ClinicalTrials.gov